| 000 | 01858 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515123614.0 | ||
| 264 | 0 | _c20080829 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a1096-9071 | ||
| 024 | 7 |
_a10.1002/jmv.21236 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiop-Ndiaye, H | |
| 245 | 0 | 0 |
_aHepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). _h[electronic resource] |
| 260 |
_bJournal of medical virology _cAug 2008 |
||
| 300 |
_a1332-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAntiretroviral Therapy, Highly Active |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xcomplications |
| 650 | 0 | 4 |
_aHIV-1 _xdrug effects |
| 650 | 0 | 4 |
_aHepacivirus _ximmunology |
| 650 | 0 | 4 |
_aHepatitis Antibodies _xblood |
| 650 | 0 | 4 |
_aHepatitis B _xcomplications |
| 650 | 0 | 4 |
_aHepatitis B Core Antigens _ximmunology |
| 650 | 0 | 4 |
_aHepatitis B Surface Antigens _xblood |
| 650 | 0 | 4 |
_aHepatitis B virus _ximmunology |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 |
_aHepatitis D _xcomplications |
| 650 | 0 | 4 |
_aHepatitis Delta Virus _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aSenegal _xepidemiology |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 700 | 1 | _aTouré-Kane, C | |
| 700 | 1 | _aEtard, J F | |
| 700 | 1 | _aLô, G | |
| 700 | 1 | _aDiaw, Pa | |
| 700 | 1 | _aNgom-Gueye, N F | |
| 700 | 1 | _aGueye, P M | |
| 700 | 1 | _aBa-Fall, K | |
| 700 | 1 | _aNdiaye, I | |
| 700 | 1 | _aSow, P S | |
| 700 | 1 | _aDelaporte, E | |
| 700 | 1 | _aMboup, S | |
| 773 | 0 |
_tJournal of medical virology _gvol. 80 _gno. 8 _gp. 1332-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jmv.21236 _zAvailable from publisher's website |
| 999 |
_c18036875 _d18036875 |
||